Premium
Hypermetabolism appears to be an adverse prognostic biomarker in amyotrophic lateral sclerosis: a potential for therapeutic intervention?
Author(s) -
Vucic S.
Publication year - 2018
Publication title -
european journal of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.881
H-Index - 124
eISSN - 1468-1331
pISSN - 1351-5101
DOI - 10.1111/ene.13470
Subject(s) - medicine , hypermetabolism , amyotrophic lateral sclerosis , adverse effect , intervention (counseling) , biomarker , oncology , intensive care medicine , physical medicine and rehabilitation , disease , psychiatry , biochemistry , chemistry
Click here to view the accompanying paper in this volume.